However, some studies concluded that hypoalbuminemia only becomes clinically significant at levels < 25 g/L [18, 19], and that albumin replacement is only covered by health insurance in Taiwan for patients with serum albumin levels < 30 g/L and who exhibit associated comorbidities. The gene discussed is ALB; the disease is Hypoalbuminemia.